Celine Hayden leads the vaccine program at ABI and brings over 15 years of experience in molecular and biochemical techniques. Since arriving at ABI, she has directed all aspects of research development, preclinical studies, regulatory compliance, and product development for oral vaccine candidates. Dr. Hayden has also been instrumental in developing bioscavenger and other pharmaceutical proteins using ABI’s plant expression platform.

Before joining ABI, Dr. Hayden was an NSF IGERT fellow at the University of Arizona where she completed her PhD in plant molecular genetics.